不同剂量阿托伐他汀钙早期治疗对急性冠状动脉综合症患者血清hsCRP\新喋呤的影响(2)
http://www.100md.com
2010年5月1日
 |
| 第1页 |
参见附件(1691KB，2页)。
参 考 文 献
[1] American Heart Association. Heart disease and stroke statistics: 2003 update. Dallas, TX: American Heart Association, 2002
[2] 朱志军,黄元伟,任森根,等.冠心病免疫激活的一个指标一新蝶呤[J]. 中国心血管杂志, 2005, 10:31-35
[3] Gregg C. Fonarow. In-Hospital Initiation of Statin Therapy in Acute Coronary Syndromes Maximizing the Early and Long-term Benefits[J]. Chest, 2005, 128:3641-3651
[4] 杨胜利,何秉贤,何学生,等.C-反应蛋白是急性冠状动脉综合征的一种危险因子[J].中华心血管病杂志, 2002, 30:618-622.
[5] Garcia-Moll X, Zouridakis E, Kaski J C. Increased serum neopterin: a marker of coronary artery disease activity in women[J]. Heart, 2000, 83:346-350
[6] Wietlicka-Kokoszanek I, Jablecka A, Smolarek I, Bogdanski P, et al. Neopterin as a prognostic marker in patients with chronic heart failure[J]. Med Sci Monit, 2010, 16:CR232-237
[7] Avanzas P, Arroyo-Espliguet R, Cosin-Sales J, et al. Prognostic value of neoptel'in levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease[J]. Am J Cardiol, 2004, 93:627-629
[8] Kausik-K. Ray, David-A. Morrow, Marc S, et al. Sabatine. Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome[J]. Circulation, 2007, 115:3071-3078
[9] Tousoulis D, Kampoli AM, Stefanadi E, Antoniades C, Siasos G, et al.New biochemical markers in acute coronary syndromes[J]. Curr Med Chem , 2008, 15:1288-1296.
您现在查看是摘要介绍页，详见PDF附件(1691KB，2页)。